BNET Industries

Market Cap:$209.6M
Last Fiscal Year Sales:$69.2M
  • Public
  • US
Dow Jones Description

Micrus develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Micrus is developing products for the treatment of hemorrhagic and ischemic stroke. Both hemorrhagic and ischemic stroke are significant causes of death worldwide. Micrus product lines consist of endovascular systems that enable a physician to gain access to the brain in a minimally invasive manner through the vessels of the arterial system. Micrus also sells accessory devices and products used in neurovascular procedures.

Chairman & CEO
John T. Kilcoyne
Number of Employees 333
Contact Information

821 Fox Lane

San Jose, California 95131

www.micruscorp....

(408) 433-1400

NAICS Code Surgical and Medical Instrument Manufacturing: 339112

Recent Events

  • Micrus Endovascular Reports Fiscal Second Quarter Revenues

    11/11/09 - Financial Announcement - View Story

  • Micrus Endovascular Inks Licensing and Development Pact with Flexible Stenting Solutions

    8/26/09 - Joint Venture / Alliance - View Story

  • Micrus Endovascular Reports Fiscal First Quarter EPS of $0.14 and Record Quarterly Revenues of $21.2...

    8/06/09 - Financial Announcement - View Story

News & Analysis

micrus endovascular corp. - All News and Analysis

Decision Makers

Name (plus bio) Position
Robert A. Stern President & Chief Operating Officer
Gordon Sangster Chief Financial Officer
David A. Watson Vice President of Research and Development
Edward F. Ruppel Vice President, Technical Operations
Robert C Colloton Vice President, US Sales and Global Marketing
William G Rigas Vice President of Sales, Asia and Latin America
Francis J. Shammo Director
Gregory H. Wolf Director
Jeffrey H. Thiel Director
L Hopkins Director
Michael L. Eagle Director

Board of Directors

Name (plus bio) Position
John T. Kilcoyne Chairman & CEO
Fred Holubow Board of Directors
Michael R. Henson Board of Directors

Mr. Kilcoyne, Micrus' Chief Executive Officer, was elected Chairman in September 2007. Prior Mr. Kilcoyne had served as our President and CEO since December 2004. From April 2002 to April 2004, Mr. Kilcoyne served as the President and Chief Executive Officer of Solace Therapeutics, Inc., a medical device company. From November 1997 to January 2002, he served as the President and Chief Executive Officer of Endonetics, Inc., a medical device company. From February 1997 to November 1997, he served as the Vice President Sales and Marketing and New Business Development at Medical Scientific, Inc., a medical device company. From July 1993 to February 1997, he served as the Director of Marketing at Microsurge, Inc., a medical device company. Mr. Kilcoyne served in various sales and marketing positions with Guidant and Boston Scientific. Mr. Kilcoyne received his B.S. from Cornell University. Mr. Kilcoyne serves as a member of the board of directors of Onset Medical, a private company.

Organization Position Status
Micrus Endovascular Corporation Chairman & CEO Current
Micrus Endovascular Corporation President Former
Medical Scientific Inc Vice President Sales and Marketing Former
Guidant Corporation Former
Boston Scientific Corporation Former
Cornell University B.S. Former

Mr. Stern was promoted to President and Chief Operating Officer in September 2007. Prior Mr. Stern had served as our Executive Vice President and Chief Financial Officer since November 2004, and Vice President, Finance and Administration and Chief Financial Officer since January 2004 and was appointed our Secretary in March 2005. From September 2000 to January 2004, Mr. Stern served as the President and Chief Executive Officer of Context Connect, Inc., a telecommunications company. From March 2000 to September 2000, he served as the Executive Vice President of Quixel Capital Group, an investment holding company. From January 1996 to March 2000, he served as the Vice President and Chief Financial Officer of InnerDyne, Inc., a medical device company. From October 1991 to January 1996, he served as Vice President, Corporate Finance and Chief Financial Officer of RhoMed Incorporated, a pharmaceutical company. Mr. Stern received his B.S. in Business Administration from the University of New Hampshire, Whittemore School of Business and Economics, and his MBA from the University of New Mexico, Anderson School of Management. Mr. Stern serves as a member of the board of directors of UltraTouch Corporation, a private company, and Context Connect, Inc

Organization Position Status
Micrus Endovascular Corporation President & Chief Operating Officer Current
Ultratouch Corporation Member of the Board of Directors Current
Context Connect, Inc. President and Chief Executive Officer Former
Micrus Endovascular Corporation Executive Vice President, Chief Financial Officer Former
Micrus Endovascular Corporation Secretary Former
The University of New Mexico Mba Former
University of New Hampshire B.S. In Business Administration Former

Mr. Sangster, 55, joined Micrus in November 2007 as our Chief Financial Officer. He most recently served as Vice President of Finance and Chief Financial Officer of HemoSense, Inc., a publicly traded point-of-care clinical diagnostics company. From August 2000 through October 2006, Mr. Sangster was Chief Financial Officer of A.P. Pharma, Inc., a publicly traded specialty pharmaceutical company. From April 1993 to July 2000, he served as A.P. Pharma's vice president of finance and controller. He is a member of the Institute of Chartered Accountants in England and Wales

Organization Position Status
Micrus Endovascular Corporation Chief Financial Officer Current
A.P. Pharma, Inc. Cfo Current
A.P. Pharma, Inc. Vice President of Finance Current
A.P. Pharma, Inc. Board of Directors Current
HemoSense, Inc. Vice President of Finance & Chief Financial Officer Former
Raychem Manager Former
A.P. Pharma, Inc. Corporate Controller Former
Coopervision, Inc. Controller Former

Mr. Watson has served as our Vice President of Research and Development since October 2004. From July 1999 to September 2004, Mr. Watson acted as an engineering and program management consultant to companies in the medical device industry, including Control Delivery Systems, Inc. from August 1999 to September 2004. From June 2001 to December 2002, he served as the Director of Engineering and Product Development for Control Delivery Systems, Inc., a medical device company. From September 1995 to July 1999, he served as Director of Engineering and Program Management, Director of Engineering and Associate Director, Engineering Development at Cythotherapeutics, Inc. Mr. Watson received his B.S. in Mechanical Engineering from California Polytechnic State University.

Organization Position Status
Micrus Endovascular Corporation Vice President of Research and Development Current
Control Delivery Systems, Inc. Director of Engineering Former
California Polytechnic State University B.S. In Mechanical Engineering Former

Mr. Ruppel joined us in June 2003 and is our Vice President, Technical Operations. From March 2001 to March 2003, Mr. Ruppel served as the Vice President of Operations of CBYON, Inc., a surgical navigation software and equipment company. From June 1994 to December 2000, he served as Director of Operations, among other management positions, for Biometric Imaging, a subsidiary of Becton, Dickinson & Company, a medical technology company. Mr. Ruppel received his B.S. in Mechanical Engineering at the University of Rochester.

Organization Position Status
Micrus Endovascular Corporation Vice President, Technical Operations Current
Becton, Dickinson & Company Former
University of Rochester B.S. In Mechanical Engineering Former

Mr. Colloton joined us in March 2005 and is our Vice President, US Sales and Global Marketing. From February 2003 to March 2005, Mr. Colloton served as the Vice President, Account and Market Development of VNUS Medical Technologies, Inc., a medical device company. Prior to this position, he also held the positions of Vice President, Worldwide Marketing and International Sales from April 2001 to February 2003 and Vice President, Worldwide Sales and Marketing from June 1999 to April 2001, at VNUS Medical Technologies, Inc. From June 1997 to June 1999, Mr. Colloton served as Vice President, Sales and Marketing of TransVascular, Inc., a medical device company. From January 1993 to June 1997, he served in various sales and marketing executive positions at Cardiometrics, Inc. Mr. Colloton received his B.S. in Business Administration at Miami University in Oxford, Ohio.

Organization Position Status
Micrus Endovascular Corporation Vice President, US Sales and Global Marketing Current
VNUS Medical Technologies, Inc. Vice President, Accounting & Market Dev Current
TransVascular, Inc. Vice President, Sales and Marketing Former

Mr. Rigas joined us in November 2004 and is our Vice President of Sales, Asia and Latin America. From October 2003 to November 2004, Mr. Rigas served as Vice President of Sales and Marketing of Bioplate Inc., a manufacturer of neurosurgical and cranial facial products. From March 2002 to November 2003, he served as Managing Partner of Neurox Inc., a medical device company. Mr. Rigas also served as the Director International Sales and Marketing of Microtherapeutics Inc., from March 2001 to March 2002. From November 1998 to January 2001, Mr. Rigas served as Vice President Worldwide Sales & Marketing of Radiance Medical Systems, a medical device company. Mr. Rigas also served as Vice President Worldwide Sales from June 1993 to December 1997 and as Vice President Sales and Marketing from June 1991 to July 1993 of Neuro Navigational Corporation, a manufacturer of neurosurgery products. Mr. Rigas received his B.S. from California State University, Long Beach.

Organization Position Status
Micrus Endovascular Corporation Vice President of Sales, Asia and Latin America Current
Bioplate, Inc. Vice President of Sales and Marketing Former
Micro Therapeutics, Inc. Director Former
California State University, Long Beach B.S. Former

Mr. Shammo has served as our director since July 2004. Since 2003, Mr. Shammo has served as President of the West Area for Verizon Wireless, a telecommunications company. From 1995 to 2003, Mr. Shammo served as Vice President and Controller of Verizon Wireless. Mr. Shammo is a Certified Public Accountant. He received his B.S. in accounting from the Philadelphia College of Textiles and Science and his MBA from LaSalle University.

Organization Position Status
Micrus Endovascular Corporation Director Current
Verizon Wireless, Inc. President Former
Verizon Wireless, Inc. Vice President and Controller Former
La Salle University Mba Former
Philadelphia University Bachelor's Degree In Accounting Former

Mr. Holubow has served as our director since July 1999. Since January 2001, Mr. Holubow has been a Managing Director of William Harris Investors, a registered investment advisory firm. From August 1982 to January 2001, Mr. Holubow served as Vice President of Pegasus Associates, a registered investment advisory firm he co-founded. He is a director of BioSante Pharmaceuticals, Inc, a pharmaceuticals company. He received his B.S. from the Massachusetts Institute of Technology and his MBA from the University of Chicago

Organization Position Status
Micrus Endovascular Corporation Board of Directors Current

Mr. Wolf served as the President of CIGNA Group Insurance as well as its subsidiaries, CIGNA Life Insurance Company of New York and Life Insurance Company of North America from 2002 to 2005. Mr. Wolf joined CIGNA in 2001 as a Division President to lead a new business development initiative. From 2000 to 2001, Mr. Wolf was Chairman and Chief Executive Officer of nextHR.com, an application service provider of human resource asset management services. From 1995 to 1999, Mr. Wolf held various positions with Humana, Inc., including Senior Vice President of Sales and Marketing, Chief Operating Officer, President and Chief Executive Officer. Mr. Wolf is a graduate of Penn State University and Central Michigan University.

Organization Position Status
Micrus Endovascular Corporation Director Current
CIGNA Corporation Division President Former
Humana Inc. Former
The Pennsylvania State University Former
Central Michigan University Former

Mr. Thiel has served as our director since 1999. Since 2003, Mr. Thiel has served as President, Chief Executive Officer and Director of Devax, Inc., a medical device company. From January 2001 until June 2002, Mr. Thiel served as President and Chief Executive Officer of Radiance Medical Systems, Inc., a medical device company. Prior to that, Mr. Thiel served as President and Chief Operating Officer of Radiance Medical Systems, Inc. from February 1999 until January 2001, and as Vice President of Operations from October 1996 until February 1999. Mr. Thiel received his B.S. in Economics from the University of Wisconsin-River Falls, and his MBA from the College of St. Thomas.

Organization Position Status
Micrus Endovascular Corporation Director Current
University of Wisconsin-River Falls B.S. In Economics Former

Organization Position Status
The State University of New York Director of the Toshiba Stroke Research Center Current
Radiology Professor Current
State University of New York at Buffalo Professor Current
Sapient Capital Management, LLC Special Sapient Network Member Current
Northpoint Domain, Inc. Chair, Neuroscience Domain Current
marketRx Inc. Board of Directors Current
Micrus Endovascular Corporation Director Current
The State University of New York Professor of Radiology Former
The State University of New York Chairman of Neurosurgery Former
Congress of Neurological Surgeons Chairman of the Joint Section Former
CNS, Inc. Scientific and Annual Meeting Chairman Former
Albany Medical College M.D. Former
Rutgers University B.A. Former
Albany Medical College Graduate Former
Rutgers University Undergraduation Former

Mr. Eagle is chairman of the board of directors of Favrille, Inc., a publicly traded company, and a member of the board of Radiant Medical, Inc. and of Siegel-Robert Corporation, both privately held companies. Mr. Eagle is a Founding Member of Barnard Life Sciences, LLC. Mr. Eagle served as Vice President of Manufacturing for Eli Lilly and Company from 1994 through 2001 and held a number of executive management positions with Eli Lilly and its subsidiaries throughout his career there. Mr. Eagle has a degree in mechanical engineering from Kettering University and an MBA from the Krannert School of Management at Purdue University. He is chairman of the board of trustees of Kettering University, on the Dean's Senior Advisory Council of the Krannert School of Management at Purdue University and on the board of directors of the Eiteljorg Museum of American Indians and Western Art.

Organization Position Status
Kettering University Chairman of the Board Current
Favrille, Inc. Chairman of the Board of Directors Current
Forward Ventures Chairman of the Board Current
Chicago Growth Partners Chairman of the Board Current
Micrus Endovascular Corporation Director Current
Theater & Arts Foundation Board of Directors Current
Radiant Medical, Inc. Board of Directors Current
Xtent Inc. Board of Directors Current
Somaxon Pharmaceuticals, Inc. Board of Directors Current
Siegel-Robert Inc. Board of Directors Current
IVAC Corporation Chief Executive Officer Former
Eli Lilly and Company Vice President of Manufacturing Former
Guidant Corporation Vice President Former
IVAC Corporation Vice President of Manufacturing Former
Favrille, Inc. Director Former
Krannert School of Management at Purdue University M.B.A. Former
Kettering University Bachelor of Science Degree In Engineering Former

Mr. Henson has served as our director since 1996, and previously served as Chairman from 1996 to September 2007. Since 2000 Mr. Henson has served as a principal manager of the MedFocus Family of Funds, a group of venture capital funds focused on emerging medical technology. In addition, since 2003 Mr. Henson has served as a general manager of the Biostar Private Equity Investment Fund, LLC, a venture capital firm. Mr. Henson joined Endologix, Inc. formerly known as Radiance Medical Systems, Inc., a medical device company, in March 1997 as president, Chief Executive Officer and Chairman of the Board of Directors, and served as a director until November 2003. In June 1997, Mr. Henson served as Chairman of the Board, Chief Executive Officer and President of Radiance Medical Systems, Inc., and served as a director until May 2002. Prior to that, Mr. Henson served as the Chief Executive Officer of Endosonics Corporation from 1988 to 1995, and as Chairman of the Board from 1993 to 1996. Mr. Henson also serves on the board of directors of several private medical companies and a charitable organization. He received his B.S. in Business Administration from Ball State University and his MBA from Ohio State University.

Organization Position Status
Micrus Endovascular Corporation Board of Directors Current
Endologix Inc. President, Chief Executive Officer and Chairman of the Board Former
Micrus Endovascular Corporation Chairman Former
Micrus Endovascular Corporation Director Former
Endologix Inc. Director Former
The Ohio State University Mba Former
Ball State University B.S. In Business Administration Former

Executive News

  • Micrus Endovascular to Present at September Investment Conferences

    Reuters - 9/03/09 - View Story

  • Micrus Endovascular Announces Positive DeltaPaq Microcoil Study Results

    Reuters - 7/23/09 - View Story

  • Micrus Endovascular Announces Positive DeltaPaq Microcoil Study Results

    Business Wire - 7/23/09 - View Story

advertisement
     MEND $13.10 +0.14 (1.08% )
Average Volume 81,371
Shares Outstanding 16.01M
Market Cap 209.7M
Year High 13.85
Year Low 4.13
Earnings Per Share 0.25
P/E Ratio 52.40
Dividend N/A
Yield N/A
advertisement